Partners & Customers
10Latest Avalon Globocare News
May 18, 2022
Save for later NEW YORK – Cell-based drug developer Avalon GloboCare said Wednesday that it has signed a memorandum of understanding with Lu Daopei Hematology Institute to co-develop precision companion diagnostics for chimeric antigen receptor (CAR)-T cell therapies. Under the deal, the company plans to work with China’s LDHI to explore CDx for both its ongoing and future cellular immunotherapy-related clinical programs. In support of this, Avalon also announced that it has appointed LDHI Executive President Hongxing Liu to its scientific and clinical advisory board. "There is a need for better, faster ways to assess patients' immune profiles to provide personalized immunotherapies," Liu said in a statement. "Patients with cancer whose care incorporates the use of appropriate companion diagnostics as part of their initial assessment have historically seen a greater survival benefit than those who were not tested," he added. Freehold, New Jersey-based Avalon called LDHI "a premiere hematology research institute" with expert capabilities for diagnostics development, including genomic, proteomic, transcriptomic, and metabolomic platforms. "LDHI will be an ideal partner that has the expertise and capabilities to conduct laboratory and analytic work on cancer biomarkers and precision medicine, as well as access to the clinical and bioinformatics database of the Lu Daopei Hospital," David Jin, Avalon's president and CEO, said in a statement. According to the company, the agreement with LDHI is subject to negotiation and execution of definitive documentation acceptable to both parties.
Avalon Globocare Acquisitions
2 Acquisitions
Avalon Globocare acquired 2 companies. Their latest acquisition was Senlang Biotech on June 14, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/14/2021 | Private Equity | $29.68M | Acquired | 2 | ||
10/30/2017 |
Date | 6/14/2021 | 10/30/2017 |
---|---|---|
Investment Stage | Private Equity | |
Companies | ||
Valuation | ||
Total Funding | $29.68M | |
Note | Acquired | |
Sources | 2 |
Avalon Globocare Partners & Customers
10 Partners and customers
Avalon Globocare has 10 strategic partners and customers. Avalon Globocare recently partnered with BOKU on December 12, 2020.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
12/30/2020 | Partner | Austria | 1 | ||
6/25/2020 | Partner | Austria | This strategic partnership with University of Natural Resources and Life Sciences leverages Avalon GloboCare Corp. 's expertise and resources in bio-manufacturing infrastructure and clinical study implementation with the scientific capabilities and deep experience of the laboratories of Professors Sleytr and Ehmoser at University of Natural Resources and Life Sciences . | 1 | |
6/25/2020 | Partner | Austria | This strategic partnership with University of Natural Resources and Life Sciences leverages Avalon GloboCare Corp. 's expertise and resources in bio-manufacturing infrastructure and clinical study implementation with the scientific capabilities and deep experience of the laboratories of Professors Sleytr and Ehmoser at University of Natural Resources and Life Sciences . | 1 | |
4/28/2020 | Partner | ||||
4/28/2020 | Partner |
Date | 12/30/2020 | 6/25/2020 | 6/25/2020 | 4/28/2020 | 4/28/2020 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | Austria | Austria | Austria | ||
News Snippet | This strategic partnership with University of Natural Resources and Life Sciences leverages Avalon GloboCare Corp. 's expertise and resources in bio-manufacturing infrastructure and clinical study implementation with the scientific capabilities and deep experience of the laboratories of Professors Sleytr and Ehmoser at University of Natural Resources and Life Sciences . | This strategic partnership with University of Natural Resources and Life Sciences leverages Avalon GloboCare Corp. 's expertise and resources in bio-manufacturing infrastructure and clinical study implementation with the scientific capabilities and deep experience of the laboratories of Professors Sleytr and Ehmoser at University of Natural Resources and Life Sciences . | |||
Sources | 1 | 1 | 1 |
Avalon Globocare Team
1 Team Member
Avalon Globocare has 1 team member, including current Chief Financial Officer, Luisa Ingargiola.
Name | Work History | Title | Status |
---|---|---|---|
Luisa Ingargiola | Chief Financial Officer | Current |
Name | Luisa Ingargiola |
---|---|
Work History | |
Title | Chief Financial Officer |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.